1st Quarter - Report
TERUMO BCT, INC. for TERUMO BCT, INC.
Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Global trade and tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| LATOYA THOMAS | — |
Health Issues HCR
S.721 - SCD Comprehensive Care Act S.752/H.R.1509 - Accelerating Kids Access to Care Act S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 Blood and cell collection, storage, and processing Blood donation supply and quality
| Lobbyist | Covered position, as disclosed |
|---|---|
| LATOYA THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.